Skip to main content

Advertisement

Table 6 Post-hoc analysis (least significant difference) comparing ratio of serum IGF-1 and IGFBP-3 for each of the six CVMI stages

From: Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators

CVMI Stage CVMI stage Mean difference Significance
1 2 .001 0.8(NS)
3 −.018* 0.01(NS)
4 −.001 0.8(NS)
5 −.012 0.09(NS)
6 .003 0.6(NS)
2 1 −.001 0.8(NS)
3 −.020* 0.009(**)
4 −.003 0.6(NS)
5 −.014 0.05(NS)
6 .001 0.8(NS)
3 1 .018* 0.016(*)
2 .020* 0.009(**)
4 .016* 0.029(*)
5 .005 0.4(NS)
6 .022* 0.005(**)
4 1 .001 0.8(NS)
2 .003 0.6(NS)
3 −.016* 0.029(*)
5 −.011 0.1(NS)
6 .005 0.4(NS)
5 1 .012 0.09(NS)
2 .014 0.05(NS)
3 −.005 0.4(NS)
4 .011 0.1(NS)
6 .016* 0.035(*)
6 1 −.003 0.6(NS)
2 −.001 0.8(NS)
3 −.022* 0.005(**)
4 −.005 0.4(NS)
5 −.016* 0.035(*)
  1. (*) Significant (P < 0.05)
  2. (**) Highly significant (P < 0.01, P < 0.001)
  3. NS not Significant